These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 17468049)

  • 1. Post-translational modifications regulate distinct functions of CARMA1 and BCL10.
    Thome M; Weil R
    Trends Immunol; 2007 Jun; 28(6):281-8. PubMed ID: 17468049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD28 stimulation triggers NF-kappaB activation through the CARMA1-PKCtheta-Grb2/Gads axis.
    Takeda K; Harada Y; Watanabe R; Inutake Y; Ogawa S; Onuki K; Kagaya S; Tanabe K; Kishimoto H; Abe R
    Int Immunol; 2008 Dec; 20(12):1507-15. PubMed ID: 18829987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NF-kappaB signaling in lymphocytes: a new cast of characters.
    Lucas PC; McAllister-Lucas LM; Nunez G
    J Cell Sci; 2004 Jan; 117(Pt 1):31-9. PubMed ID: 14657271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Negative feedback loop in T cell activation through IkappaB kinase-induced phosphorylation and degradation of Bcl10.
    Lobry C; Lopez T; Israël A; Weil R
    Proc Natl Acad Sci U S A; 2007 Jan; 104(3):908-13. PubMed ID: 17213322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of calmodulin with Bcl10 modulates NF-kappaB activation.
    Edin S; Oruganti SR; Grundström C; Grundström T
    Mol Immunol; 2010 Jul; 47(11-12):2057-64. PubMed ID: 20439115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CARD-Bcl10-Malt1 signalosomes: missing link to NF-kappaB.
    Wegener E; Krappmann D
    Sci STKE; 2007 May; 2007(384):pe21. PubMed ID: 17473310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A requirement for CARMA1 in TCR-induced NF-kappa B activation.
    Wang D; You Y; Case SM; McAllister-Lucas LM; Wang L; DiStefano PS; Nuñez G; Bertin J; Lin X
    Nat Immunol; 2002 Sep; 3(9):830-5. PubMed ID: 12154356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-2 induces NF-kappaB activation through BCL10 and affects its subcellular localization in natural killer lymphoma cells.
    Chan KK; Shen L; Au WY; Yuen HF; Wong KY; Guo T; Wong ML; Shimizu N; Tsuchiyama J; Kwong YL; Liang RH; Srivastava G
    J Pathol; 2010 Jun; 221(2):164-74. PubMed ID: 20235165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-apoptotic action of API2-MALT1 fusion protein involved in t(11;18)(q21;q21) MALT lymphoma.
    Hosokawa Y
    Apoptosis; 2005 Jan; 10(1):25-34. PubMed ID: 15711920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CARD9 versus CARMA1 in innate and adaptive immunity.
    Hara H; Saito T
    Trends Immunol; 2009 May; 30(5):234-42. PubMed ID: 19359218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CaMKII targets Bcl10 in T-cell receptor induced activation of NF-κB.
    Oruganti SR; Edin S; Grundström C; Grundström T
    Mol Immunol; 2011 Jul; 48(12-13):1448-60. PubMed ID: 21513986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bcl10 is phosphorylated on Ser138 by Ca2+/calmodulin-dependent protein kinase II.
    Ishiguro K; Ando T; Goto H; Xavier R
    Mol Immunol; 2007 Mar; 44(8):2095-100. PubMed ID: 17052756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The roles of CARMA1, Bcl10, and MALT1 in antigen receptor signaling.
    Lin X; Wang D
    Semin Immunol; 2004 Dec; 16(6):429-35. PubMed ID: 15541657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determining the destiny of NF-kappa B after TCR ligation: it's CARMA1.
    Bunnell SC
    Mol Interv; 2002 Oct; 2(6):356-60, 338. PubMed ID: 14993411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation and functional characterization of a BCL10-inhibitory peptide that represses NF-kappaB activation.
    Marasco D; Stilo R; Sandomenico A; Monti SM; Tizzano B; de Capua A; Varricchio E; Liguoro D; Zotti T; Formisano S; Ruvo M; Vito P
    Biochem J; 2009 Aug; 422(3):553-61. PubMed ID: 19538180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics of CARMA1-BCL10-MALT1-A20-NF-κB expression in T cell-acute lymphocytic leukemia.
    Ma Y; Liao Z; Xu Y; Zhong Z; Wang X; Zhang F; Chen S; Yang L; Luo G; Huang X; Huang S; Wu X; Li Y
    Eur J Med Res; 2014 Nov; 19(1):62. PubMed ID: 25384343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Striking back at the activator: how IkappaB kinase terminates antigen receptor responses.
    Hinz M; Scheidereit C
    Sci STKE; 2007 May; 2007(384):pe19. PubMed ID: 17473308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Post-translational modifications regulating the activity and function of the nuclear factor kappa B pathway.
    Perkins ND
    Oncogene; 2006 Oct; 25(51):6717-30. PubMed ID: 17072324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of caspase recruitment domain (CARD) membrane-associated guanylate kinase 1 (CARMA1) and CARD9 in primary gastric B-cell lymphoma.
    Nakamura S; Nakamura S; Matsumoto T; Yada S; Hirahashi M; Suekane H; Yao T; Goda K; Iida M
    Cancer; 2005 Nov; 104(9):1885-93. PubMed ID: 16177990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CARMA3/Bcl10/MALT1-dependent NF-kappaB activation mediates angiotensin II-responsive inflammatory signaling in nonimmune cells.
    McAllister-Lucas LM; Ruland J; Siu K; Jin X; Gu S; Kim DS; Kuffa P; Kohrt D; Mak TW; Nuñez G; Lucas PC
    Proc Natl Acad Sci U S A; 2007 Jan; 104(1):139-44. PubMed ID: 17101977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.